Business
BullFrog AI on Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences
White paper discusses how BullFrog AI’s bfPREP™ embodies data harmonization, enabling biopharma organizations to convert noisy, document-heavy data into standardized, AI-ready datasetsGAITHERSBURG, Md., Jan. 27, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable insights, publishes a white paper titled, “Data Harmo
About this update from Bullfrog Ai Holdings, Inc.
[{"type":"image","alt":"BullFrog AI Holdings, Inc.","displaySize":"","headline":null,"caption":"BullFrog AI Holdings, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":73,"url":"https://media.zenfs.com/en/globenewswire.com/40a6d1d7288dd7624185c5755b024c0e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/cckXAhHY1jCBABonzk6CjQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwMjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/40a6d1d7288dd7624185c5755b024c0e","width":300,"height":73}},"lazy":false},{"type":"text","content":"White paper discusses how BullFrog AI’s bfPREP™ embodies data harmonization, enabling biopharma organizations to convert noisy, document-heavy data into standardized, AI-ready datasets","length":184,"tagName":"p"},{"type":"text","content":"GAITHERSBURG, Md., Jan. 27, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable insights, publishes a white paper titled, “Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences,” with a discussion on how BullFrog AI’s bfPREPTM immediately recognizes reliable patterns to transform raw biomedical data into harmonized, clinically contextualized formats, providing reliable insights and trustworthy analytical assets to assist in drug development.","length":674,"tagName":"p"},{"type":"text","content":"“The rush to apply AI in biopharma drug development has resulted in many AI initiatives that fail, not due to the algorithm, but due to the resulting analysis that reflect data processing idiosyncrasies rather than biology,” said BullFrog AI Founder and CEO Vin Singh. “The white paper discusses how BullFrog makes messy biomedical data usable, with our experienced data team quick to recognize the typical state of the underlying data, which is often fragmented across sources and trapped in formats that resist automated processing. Our proprietary bfPREPTM addresses all this by harmonizing and standardizing raw data into clean, analysis-ready datasets so that teams can comfortably trust their inputs.”","length":707,"tagName":"p"},{"type":"text","content":"The white paper outlines where modern AI pipelines break in life sciences and presents a practi...